![Sera Prognostics, Inc. logo](/logos/SERA.webp)
Sera Prognostics, Inc.
NASDAQ:SERA
Overview | Financials
Company Name | Sera Prognostics, Inc. |
Symbol | SERA |
Currency | USD |
Price | 7.25 |
Market Cap | 234,905,793 |
Dividend Yield | 0% |
52-week-range | 1.52 - 12.355 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Ms. Evguenia Lindgardt M.B.A. |
Website | https://seraprognostics.com |
An error occurred while fetching data.
About Sera Prognostics, Inc.
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD